2020 annual financial data
Aptevo Therapeutics 2020 Net margin
Direct answer
Net margin was -411.93%.
Operating income was -27,494,000 USD and net income was -17,750,000 USD.
Operating cash flow was -29,318,000 USD.
Get free Aptevo Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 4,309,000 USD
- Operating income
- -27,494,000 USD
- Net income
- -17,750,000 USD
- Operating cash flow
- -29,318,000 USD